Bladder cancer survival similar for partial, radical cystectomy

This article originally appeared here.
Bladder Cancer Survival Similar for Partial, Radical Cystectomy
Bladder Cancer Survival Similar for Partial, Radical Cystectomy

(HealthDay News) -- For select patients with bladder cancer, there is no difference in metastasis-free or cancer-specific survival with partial cystectomy (PC) or radical cystectomy (RC), but there is an increased risk for intravesical recurrence for those treated with PC, according to research published in the October issue of The Journal of Urology.

In an effort to evaluate the long-term oncologic outcomes in bladder cancer, John J. Knoedler, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues conducted a matched, case-control study involving 86 patients who underwent PC and 167 who underwent RC.

After a median follow-up period of 6.2 years, the researchers found no between-group difference in the 10-year distant recurrence-free survival or cancer-specific survival. While significantly fewer PC-treated patients experienced an extravesical pelvic tumor recurrence compared with RC-treated patients (5 versus 17 percent), PC-treated patients were at higher risk of intravesical tumor recurrence. Intravesical recurrence occurred in 38 percent of PC-treated patients, and, of these, 19 percent eventually underwent a RC procedure.

"Our matched analysis demonstrated no difference in cancer-specific survival or metastasis-free survival between patients treated with PC and those treated with RC," the authors write. "Patients who undergo PC remain at risk for intravesical recurrence with almost 20 percent requiring subsequent RC. Thus patients considering PC should be counseled and surveilled accordingly."

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs